Hoya: Fiscal 3Q15 Financial Results

(in ¥ billion)	2Q15	2Q16	6 mo. 15	6 mo. 16
Revenues	121.2	130.2	234.3	256.4
*Growth*		7%		9%
Profit for the term	27.3	27.1	45.3	50.8

Hoya Corporation announced financial results for the second quarter ended September 30, 2015.

During the quarter, the Group revenues totaled ¥130,165 million yen, increasing by 7.4% from the same period last year.

Pre-tax profit for the quarter was ¥33,858 million, while profit for the quarter was ¥27,140 million; decrease of 1.2% and 0.7%, respectively from last year when foreign exchange gain was reported due to the decline in the value of yen against U.S. dollar.

In the Information Technology segment, demand of semiconductor and LCD panel-related products for smartphones and other telecommunications devices was favorable and drove sales expansion. On the other hand, sales in volume terms of glass disks for HDDs were below their levels of the same quarter last year. Among imaging related products, in view of the shrinkage of the market for digital cameras, sales overall held firm due to commercialization of products for other applications.

In the Life Care segment, sales in the eyeglass lens business expanded in overseas markets. The contact lens retail business reported a major increase compared to the same quarter last year when sales declined following the increase in Japan’s consumption tax. Sales of medical endoscopes weakened, however, thanks to the ongoing recovery sales in the intraocular lens business for cataract surgery, overall sales in the medical related products business were strong. In addition, along with the positive impact of the depreciation of the yen, segment sales rose year on year.

For the six months ended September 30, 2015, revenues totaled ¥256,403 million, increasing by 9.4% year-on-year. Pre-tax profit posted ¥64,759 million and profit for the term was ¥50,790 million, both the best first-half profit total in the company’s history.

“Today we announced a new share repurchase program with a maximum of 14 million shares and ¥60 billion. Our policy to allocate resources in M&A opportunities and to use excess cash to reward shareholders continues,” said Hiroshi Suzuki, CEO. “Overall the Life Care segment showed healthy growth, including intraocular lens, contact lens retail as well as eyeglass lens businesses.”

The company also announced the interim dividends of ¥30 per share of common stock.